Related Experiment Video
Updated: Jan 30, 2026

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
Mir20a/106a-WTX axis regulates RhoGDIa/CDC42 signaling and colon cancer progression
Gui-Fang Zhu1,2,3, Yang-Wei Xu1,2,3, Jian Li1,2,3
1Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, GuangDong, 510515, China.
Abstract:
Wilms tumor gene on the X chromosome (WTX) is a putative tumor suppressor gene in Wilms tumor, but its expression and functions in other tumors are unclear. Colorectal cancer (CRC) is the third leading cause of cancer-related deaths in women and the second leading cause in men in the United States. We demonstrated that WTX frequently lost in CRC which was highly correlated with cell proliferation, tumor invasion and metastasis. Mechanistically, WTX loss disrupts the interaction between RhoGDIα and CDC42 by losing of the binding with RhoGDIα and triggers the activation of CDC42 and its downstream cascades, which promotes CRC development and liver metastasis. The aberrant upregulation of miR-20a/miR-106a were identified as the reason of WTX loss in CRC both in vivo and in vitro. These study defined the mechanism how miR-20a/miR-106a-mediated WTX loss regulates CRC progression and metastasis, and provided a potential therapeutic target for preventing CRC progression.
Insights
Wilms tumor gene on the X chromosome (WTX) loss promotes colorectal cancer (CRC) progression and metastasis by disrupting RhoGDIα/CDC42 interaction. Aberrant miR-20a/miR-106a upregulation causes WTX loss, offering a potential therapeutic target for CRC.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Wilms tumor gene on the X chromosome (WTX) is a known tumor suppressor, but its role in colorectal cancer (CRC) is largely unknown.
- CRC is a leading cause of cancer death, necessitating research into its underlying mechanisms and potential therapeutic targets.
Purpose of the Study:
- To investigate the role of WTX in colorectal cancer (CRC) development and metastasis.
- To elucidate the molecular mechanisms by which WTX loss contributes to CRC progression.
- To identify potential therapeutic strategies targeting WTX regulation in CRC.
Main Methods:
- Analysis of WTX expression in CRC tissues and correlation with clinicopathological features.
- In vitro and in vivo experiments to study the functional impact of WTX loss on CRC cells.
- Investigation of the interaction between WTX, RhoGDIα, and CDC42 signaling pathways.
- Identification of microRNAs (miRNAs) regulating WTX expression in CRC.
Main Results:
- WTX is frequently lost in CRC, correlating significantly with increased cell proliferation, invasion, and metastasis.
- WTX loss disrupts the RhoGDIα-CDC42 interaction, activating CDC42 signaling and promoting CRC.
- Aberrant upregulation of miR-20a and miR-106a was identified as a key mechanism for WTX loss in CRC.
- These findings establish a novel molecular pathway regulating CRC progression and liver metastasis.
Conclusions:
- WTX functions as a tumor suppressor in CRC, and its loss promotes tumor progression and metastasis.
- The miR-20a/miR-106a-WTX axis represents a critical regulatory mechanism in CRC.
- Targeting this pathway may offer a novel therapeutic strategy for preventing CRC progression and metastasis.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Hypothalamic-Pituitary Axis
Hormonal Regulation
The Colonization of Land
Positive Regulator Molecules
GTPases and their Regulation
Large G-proteins,...

